Point72 Asset Management’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
FLAM
NI
WCA
Point72 Asset Management's HCAT Position: Q1 2025 in Review
Point72 Asset Management sold out of Health Catalyst (HCAT) in Q1 2025, closing a stake of 215,160 shares — an estimated $1.52M sold.
Point72 Asset Management first reported a position in HCAT in Q1 2020 and held it in 18 quarters. The position peaked at $39.3M in Q3 2023. 165 funds tracked by Wall St. Rank hold HCAT as of Q1 2025.
- Point72 Asset Management reported no remaining Health Catalyst position as of Q1 2025 after selling out during the quarter.
- Point72 Asset Management sold 215,160 Health Catalyst shares in Q1 2025, an estimated $1.52M.
- Point72 Asset Management first reported a position in Health Catalyst in Q1 2020 and held it in 18 quarters.
- Point72 Asset Management's Health Catalyst position peaked at $39.3M in Q3 2023.
- 165 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2025.
Based on Point72 Asset Management's 13F filing for Q1 2025, filed 15 May 2025.